Journal
PEDIATRIC PULMONOLOGY
Volume 45, Issue 2, Pages 120-126Publisher
WILEY
DOI: 10.1002/ppul.21151
Keywords
community-acquired pneumonia; human bocavirus; enzyme immunoassay; seroconversion; respiratory viruses
Categories
Funding
- Academy of Finland [1122539]
- Helsinki University Central Hospital Research Education
- Medical Society of Finland
- Sigrid Juselius Foundation
Ask authors/readers for more resources
Working Hypothesis: Human bocavirus (HBoV) is a newly identified parvovirus frequently found in children suffering from acute respiratory and intestinal infections. The aim of the present study was to evaluate, by using a newly developed antibody assay, the role of HBoV in pediatric community-acquired pneumonia (CAP) and the seropositivity rate to HBoV in a prospective study in North-Italian children. Materials/Patients and Methods: During a 15-month study period, 124 children were admitted due to presumptive pneumonia, and in 101 of them, pneumonia was radiologically confirmed. The etiology of CAP was studied by antibody assays to 16 microbes, including the newly developed enzyme immunoassay for HBoV Results: Serological evidence of acute HBoV infection was found in 12 (12%) children, being single in 7 and mixed in 5 cases (4 with other viruses and 3 with bacteria). IgM was positive in 11 cases. A diagnostic rise in IgG antibodies between paired sera was observed in six cases. HBoV was the second most common virus next to respiratory syncytial virus (117%). The seropositivity rate to HBoV increased with age, reaching nearly 100% before school age. Conclusions: The present results show that HBoV is able to induce significant antibody responses and suggest that HBoV may be a fairly common cause of pneumonia in children. Seroconversion to HBoV in most children takes place in early childhood. Pediatr Pulmonol. 2010;45:120-126. (C) 2009 Wiley-Liss, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available